Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

Bullboard Posts
Comment by HappyInvestingon Nov 01, 2016 8:00pm
127 Views
Post# 25413173

RE:RE:RE:3rd qt revenue estimate

RE:RE:RE:3rd qt revenue estimateThe Q3 earnings is quite irrelevant as everyone knows the company is still optiminzing Caribou.  Q4-16 and Q1-17 will be more telling of profitability and cash flow.  Unlike many other companies, Investors are not in this stock for the quarterly earnings.  They are in it because it's both a near-term and long-term growth stock.  For example, There was significant growth in metal production in Q3 over Q2, and there should be even more production in Q4 over Q3, and so as we move through each quarter in 2017.   The drilling at Santander points to increased mine life, and higher grades, and a case for doubling the expansion from 2,000 tpd to 4,000 tpd.  PEAs for Halfmile and Stratmat underpin additional value in the company moving forward and we should see those PEAs in Q1-2017.  Combine all the above positives (and I'm sure I've missed some things) with a rising zinc and lead price environment, particularly due to an acute supply deficit ===>>> and you've got one of the most explosive growth stories out there.   That's why this is a top pick of many if not most of the analysts.  

The only thing that's relevant in Q3 is the fact that the two operations are now generating cash and no further dilution is warranted, and that the company has started to repay some debt.   Whether it's an EPS of 1c or 2c is not that relevant.   It's only a whif of what's coming in the coming quarters.

Growth story, Growth story, Growth story, Growth story ........

Does that make sense?   

  
Bullboard Posts